Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Almujtama Alraida Medical CoSAU:9592 13 EV-to-FCF is 15.19 as of Aug. 19, 2026, which is 127% above its 10-year median of 6.69. GuruFocus rates SAU:9592 with a GF Score™ of 13/100. The stock has 4 warning signs investors should review. Among 409 Healthcare Providers & Services companies, Almujtama Alraida Medical Co ranks better than 56.23% on this metric.
The historical rank and industry rank for Almujtama Alraida Medical Co's EV-to-FCF or its related term are showing as below:
SAU:9592'
s EV-to-FCF Range Over the Past 10 Years
Min: -287.28 Med: 6.69 Max: 15.19
Current: 15.19
During the past 5 years, the highest EV-to-FCF of Almujtama Alraida Medical Co was 15.19. The lowest was -287.28. And the median was 6.69.
SAU:9592's EV-to-FCF is ranked better than 56.23% of 409
companies
in the Healthcare Providers & Services industry
Industry Median: 18.66
vs SAU:9592: 15.19
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Almujtama Alraida Medical Co (SAU:9592) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Almujtama Alraida Medical Co's PE Ratio (TTM) for today is calculated as:
Almujtama Alraida Medical Co's share price for today is ﷼21.48.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Almujtama Alraida Medical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was ﷼0.880.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Almujtama Alraida Medical Co EV-to-FCF Related Terms
Almujtama Alraida Medical Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Almujtama Alraida Medical Co EV-to-FCF Competitor Comparison
For the Pharmaceutical Retailers subindustry, Almujtama Alraida Medical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Almujtama Alraida Medical Co EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Almujtama Alraida Medical Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Almujtama Alraida Medical Co's EV-to-FCF falls into.
Almujtama Alraida Medical Co's current Enterprise Value is ﷼379.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Almujtama Alraida Medical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was ﷼25.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Almujtama Alraida Medical Co (SAU:9592) has a EV-to-FCF of 15.19 as of Aug. 19, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Almujtama Alraida Medical Co and its competitors. This is 127% above median its historical median of 6.69. According to the industry distribution chart, Almujtama Alraida Medical Co ranks #179 out of 409 companies in the Healthcare Providers & Services industry, placing it in the top 43.8%.
Is Almujtama Alraida Medical Co's EV-to-FCF too high?
Almujtama Alraida Medical Co's current EV-to-FCF of 15.19 is 127% above median its 10-year median of 6.69. The Healthcare Providers & Services industry median EV-to-FCF is 18.66. Almujtama Alraida Medical Co's value of 15.19 is 18.6% below this industry median. Based on the distribution chart, Almujtama Alraida Medical Co ranks #179 out of 409 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Almujtama Alraida Medical Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Almujtama Alraida Medical Co's EV-to-FCF compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Almujtama Alraida Medical Co ranks #179 out of 409 companies for EV-to-FCF. This puts Almujtama Alraida Medical Co in the upper half of its industry. The industry median EV-to-FCF is 18.66. Almujtama Alraida Medical Co's value of 15.19 is 18.6% below this benchmark. While the company's 10-year median is 6.69 vs. the industry median of 18.66, Almujtama Alraida Medical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.66, based on 409 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Almujtama Alraida Medical Co's current EV-to-FCF of 15.19 is 18.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Almujtama Alraida Medical Co and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Almujtama Alraida Medical Co's current EV-to-FCF is 15.19, which is 127% above median its own 10-year median of 6.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almujtama Alraida Medical Co stock overvalued right now?
Almujtama Alraida Medical Co (SAU:9592) has a current EV-to-FCF of 15.19. The current EV-to-FCF is 15.19, which is 127% above median its 10-year median of 6.69 and 18.6% below the Healthcare Providers & Services industry median of 18.66. Almujtama Alraida Medical Co's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Almujtama Alraida Medical Co (SAU:9592), the current EV-to-FCF is 15.19 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Almujtama Alraida Medical Co is a company having its core operations include operating pharmacies and retailing pharmaceutical products such as medicines and cosmetic products and medical equipment and medical supplies. It also provides pharmaceutical services in the Kingdom of Saudi Arabia.
13GF Score
Get the complete analysis for SAU:9592
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9592 has been successfully added to your 
